Security
HELP · CYBIN INC.
HELPNASDAQCommon stockCurrentCIK 1833141Updated Sep 24, 2026
HELP price & chart
Loading TradingView…
NASDAQ:HELP on TradingView ↗In the news
A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout ↗
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time ↗
Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · CADcash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossCAD | -113,137,000Source | -78,080,000Source | -47,490,000Source | -67,631,000Source |
| Additional Financial Items | ||||
| AdjustmentsForDecreaseIncreaseInTradeAccountReceivableCAD | -1,409,000Source | -1,089,000Source | -948,000Source | -773,000Source |
| AdjustmentsForSharebasedPaymentsCAD | 42,869,000Source | 13,886,000Source | 4,686,000Source | 18,030,000Source |
| GeneralAndAdministrativeExpenseCAD | 45,368,000Source | 32,588,000Source | 21,341,000Source | 28,222,000Source |
| GoodwillCAD | 51,487,000Source | 47,475,000Source | 24,792,000Source | 22,892,000Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesCAD | 290,000Source | 149,000Source | — | — |
| ProceedsFromIssuingSharesCAD | 20,487,000Source | 254,600,000Source | 13,202,000Source | 31,507,000Source |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesCAD | — | 689,000Source | 3,167,000Source | 415,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cost of Goods and Services Sold | — | — | — | — |
| Total RevenueCAD | — | — | — | 0Source |
| Additional Financial Items | ||||
| BasicEarningsLossPerShareCAD/shares | -5.59Source | -0.25Source | -0.26Source | -0.4Source |
| DilutedEarningsLossPerShareCAD/shares | — | — | -0.26Source | -0.4Source |
| EmployeeBenefitsExpenseCAD | 13,146,000Source | 8,248,000Source | 6,272,000Source | 7,468,000Source |
| GeneralAndAdministrativeExpenseCAD | 45,368,000Source | 32,588,000Source | 21,341,000Source | 28,222,000Source |
| GrossProfitCAD | — | — | — | 0Source |
| ImpairmentLossRecognisedInProfitOrLossGoodwillCAD | 0Source | 0Source | — | 0Source |
| IncomeTaxExpenseContinuingOperationsCAD | 0Source | 0Source | 0Source | 0Source |
| InterestExpenseOnLeaseLiabilitiesCAD | 7,000Source | 8,000Source | — | — |
| OtherIncomeCAD | 30,010,000Source | 756,000Source | 4,028,000Source | — |
| ProfessionalFeesExpenseCAD | 4,156,000Source | 4,918,000Source | 2,142,000Source | 3,275,000Source |
| ResearchAndDevelopmentExpenseCAD | 54,910,000Source | 32,362,000Source | 25,491,000Source | 17,586,000Source |
| RevenueFromInterestCAD | 8,289,000Source | 619,000Source | 603,000Source | 241,000Source |